Connecting you to content on EBSCOhost

Works by Meresse, Valerie

Results: 6

1

First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors.

Published in:

2016

By:

Dienstmann, Rodrigo;
Lassen, Ulrik;
Cebon, Jonathan;
Desai, Jayesh;
Brown, Michael;
Evers, Stefan;
Su, Fei;
Zhang, Weijiang;
Boisserie, Frederic;
Lestini, Brian;
Schostack, Kathleen;
Meresse, Valerie;
Tabernero, Josep;
Brown, Michael P

Publication type:

journal article

2

Differences in the Biologic Activity of 2 Novel MEK Inhibitors Revealed by <sup>18</sup>F-FDG PET: Analysis of Imaging Data from 2 Phase I Trials.

Published in:

Journal of Nuclear Medicine, 2012, v. 53, n. 12, p. 1836, doi. 10.2967/jnumed.112.109421

By:

Kraeber-Bodéré, Françoise;
Carlier, Thomas;
Naegelen, Valérie Meresse;
Shochat, Eliezer;
Lumbroso, Jean;
Trampal, Carlos;
Nagarajah, James;
Chua, Sue;
Hugonnet, Florent;
Stokkel, Marcel;
Gleeson, Fergus;
Tessier, Jean

Publication type:

Article

3

Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin.

Published in:

Cancer (0008543X), 2020, v. 126, n. 22, p. 4936, doi. 10.1002/cncr.33145

By:

Hassan, Raffit;
Alewine, Christine;
Mian, Idrees;
Spreafico, Anna;
Siu, Lillian L.;
Gomez‐Roca, Carlos;
Delord, Jean‐Pierre;
Italiano, Antoine;
Lassen, Ulrik;
Soria, Jean‐Charles;
Bahleda, Rastilav;
Thomas, Anish;
Steinberg, Seth M.;
Peer, Cody J.;
Figg, William D.;
Niederfellner, Gerhard;
Méresse Naegelen, Valérie;
Pastan, Ira

Publication type:

Article

4

Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.

Published in:

EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0358-8

By:

Jauw, Yvonne W. S.;
Huisman, Marc C.;
Nayak, Tapan K.;
Vugts, Danielle J.;
Christen, Randolph;
Naegelen, Valerie Meresse;
Ruettinger, Dominik;
Heil, Florian;
Lammertsma, Adriaan A.;
Verheul, Henk M. W.;
Hoekstra, Otto S.;
van Dongen, Guus A. M. S.;
Menke-van der Houven van Oordt, C. Willemien

Publication type:

Article

5

In vivo induction of functional FcγRI (CD64) on neutrophils and modulation of blood cytokine mRNA levels in cancer patients treated with G-CSF (rMetHuG-CSF).

Published in:

British Journal of Haematology, 1998, v. 100, n. 3, p. 550, doi. 10.1046/j.1365-2141.1998.00597.x

By:

Michon, Jean M.;
Gey, Alain;
Moutel, Sandrine;
Tartour, Eric;
Meresse, Valerie;
Fridman, Wolf;
Teillaud, Jean-Luc;
Michon, Jean

Publication type:

Article

6

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors.

Published in:

Neuro-Oncology, 2011, v. 13, n. 1, p. 109

By:

Geoerger, Birgit;
Hargrave, Darren;
Thomas, Fabienne;
Ndiaye, Anna;
Frappaz, Didier;
Andreiuolo, Felipe;
Varlet, Pascale;
Aerts, Isabelle;
Riccardi, Riccardo;
Jaspan, Timothy;
Chatelut, Etienne;
Le Deley, Marie-Cecile;
Paoletti, Xavier;
Saint-Rose, Christian;
Leblond, Pierre;
Morland, Bruce;
Gentet, Jean-Claude;
Méresse, Valérie;
Vassal, Gilles

Publication type:

Article